The Royal Brisbane and Women's Hospital is a tertiary hospital located in Herston, a suburb of Brisbane, Queensland, Australia. It is operated by Queensland Health, a department of the Queensland Government.

There are 929 beds in QCGC, Royal Brisbane and Women's Hospital.

During the past decade, QCGC, Royal Brisbane and Women's Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "QCGC, Royal Brisbane and Women's Hospital" are "Cancer" (1 trials) and "Uterine Cancer" (1 trials). Many other conditions were trialed in "QCGC, Royal Brisbane and Women's Hospital" in a lesser frequency.

Most popular intervention types in "QCGC, Royal Brisbane and Women's Hospital" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Caprosyn subcuticular sutures." (1 trials), "Monocryl subcuticular sutures." (1 trials), "Paclitaxel, Carboplatin" (1 trials) and "Skin staples;" (1 trials). Other intervention names were less common.

The vast majority of trials in "QCGC, Royal Brisbane and Women's Hospital" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "QCGC, Royal Brisbane and Women's Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in QCGC, Royal Brisbane and Women's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in QCGC, Royal Brisbane and Women's Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".